US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CAR-T Concept

1,839.69

-21.4523-1.15%

Number of Gainers:- -

Number of Losers:2

Number of Flat:- -

PE:- -

High:1,865.38

Open:1,865.38

Low:1,829.47

Close:1,861.14

Volume:5.11M

Turnover:755.08M

Market Cap:474.21B

Float Cap:465.08B

Loading ...

Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run

Simply Wall St.

Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors

Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo

Gilead Breaks Ground on Foster City Biologics Facility in $32 Billion US Investment Push

Gilead Sciences Director Anthony Welters Disposes of USD 2.64 Million in Common Shares

US FDA Approves Gilead's Once-Daily Combination Pill for HIV Treatment

U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults with Hiv, Including Those on Complex Regimens

THOMSON REUTERS

Novartis AG Falls Thursday, Underperforms Market

Moderna Inc. Stock Falls 5.8%, Underperforms Peers

Novartis Secures New Chinese Approval for Key Radiopharmaceutical Therapy

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

BeOne Medicines' Tacabrutideg Presents 'Sizable Opportunity' in CSU, RBC Says

MT Newswires Live

Moderna Inc. Stock Slides 4.3%, Underperforms Peers

Lakefront Biotherapeutics Wins FDA Orphan Drug Status for Gamgertamig in Pemphigus

Funds: What a Top Biotech Fund is Buying Now

Gilead Declares Q3 2026 Dividend of R$ 0.24 Per Unit

Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors

Moderna Inc. Stock Slips 23.5%, Underperforms Peers

Moderna Inc. Stock Rallies 177.0%, Outperforms Peers

Novartis AG Stock (NVS) Moved Up by 3.82% on Aug 19: Key Drivers Unveiled

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/BK4578/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4578","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","market":"US","secType":"PLATE","nameCN":"CAR-T Concept","latestPrice":1839.6881,"timestamp":1787947199999,"preClose":1861.1404,"halted":0,"volume":5114041,"delay":0,"changeRate":-0.011526,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-21.452271,"latestTime":"08-28 16:00:00 EDT","open":1865.3837,"high":1865.3837,"low":1829.4686,"amount":755075597.091417,"amplitude":0.019297,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788163200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":8.941888,"peRate":50.145795,"turnoverRate":0.001655,"increases":0,"decrements":2,"flats":0,"marketCap":474211696640,"floatMarketCap":465077878784},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","high":1865.3837,"amplitude":0.019297,"preClose":1861.1404,"low":1829.4686,"pbRate":"8.941888","latestPrice":1839.6881,"volume":5114041,"delay":0,"open":1865.3837,"prevYearClose":1612.5378,"prevWeekClose":1879.413,"prevMonthClose":1782.72,"prevQuarterClose":1768.1697,"fiveDayClose":1879.413,"twentyDayClose":1782.72,"sixtyDayClose":1684.6511,"secType":"PLATE","market":"US","turnoverRate":0.001655,"peRate":50.145795,"marketCap":474211696640,"floatMarketCap":465077878784,"timestamp":1787947199999,"nameCN":"CAR-T Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4578\",,,,undefined,":{"bkCode":"BK4578","up":0,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4578\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663043488","title":"Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2663043488","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663043488?lang=en_us&edition=fundamental","pubTime":"2026-08-30 07:30","pubTimestamp":1788046226,"startTime":"0","endTime":"0","summary":"Gilead Sciences stock has delivered very strong gains over the past few years, yet current valuation checks still suggest the shares screen as inexpensive on several metrics. The question for investors is how that strong track record and the latest product approvals align with a profile that continues to lean cheap.\n\nOver 5 years the stock has returned about 143%, which puts recent moves in the context of a long, powerful run that investors now need to judge against today’s pricing.\nThe...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-stays-cheap-after-a-143-five-year-run","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-stays-cheap-after-a-143-five-year-run","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4550","LU1066053197.SGD","IE00B3T34201.USD","LU1934455863.HKD","BIB","LU0234570918.USD","LU2112291526.USD","TMED","BK4578","LU0114720955.EUR","BK4585","LU0882574055.USD","LU0289739699.SGD","LU1571399168.USD","BK4588","GILD","BK4583","LU0122379950.USD","LU1023059063.AUD","LU2089984988.USD","LU1934455194.USD","LU2468319806.SGD","SG9999015945.SGD","BK4139","IBBQ","SG9999015978.USD","LU0965509010.AUD","BMED","IBB","LU0965508806.USD","BK4532","IE00BZ1G4Q59.USD","TBXU","IE00B19Z3B42.SGD","LU2324357040.USD","LU0109394709.USD","LU1061106388.HKD","LU0058720904.USD","BK4566","BBH","LU1934455277.USD","MEDI","LU1839511570.USD","BK4568","LU0823416689.USD","LU1430594728.SGD","LU1066051498.USD","IE00BKVL7J92.USD","LU0965509283.SGD","LU1585245621.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663701587","title":"Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663701587","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663701587?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:35","pubTimestamp":1787949300,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slid 2.14% to $145.68 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,711.76 and Dow Jones Industrial Average  falling 0.02% to 53,559.99.Gilead Sciences Inc. closed 7.38% short of its 52-week high of $157.29, which the company achieved on February 11th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  rose 0.85% to $268.04, Pfizer Inc.  fell 0.21% to $27.96, and Abbott Laboratories  rose 0.79% to $112.47.Trading volume  remained 3.2 million below its 50-day average volume of 7.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455194.USD","BK4588","BK4550","IE00BZ1G4Q59.USD","LU0114720955.EUR","SG9999015986.USD","TBXU","BBH","LU2324357040.USD","BMED","BK4568","LU0823416689.USD","LU1023059063.AUD","LU1037948541.HKD","IBB","LU1674673691.USD","IE00B3T34201.USD","LU1066051498.USD","LU1057294990.SGD","SG9999015952.SGD","LU2468319806.SGD","GILD","LU0882574055.USD","LU0058720904.USD","TMED","IBBQ","LU0889565916.HKD","SG9999015978.USD","IE0002270589.USD","LU0965508806.USD","MEDI","LU1430594728.SGD","LU1674673428.USD","LU0234570918.USD","LU0861579265.USD","LU0289739699.SGD","BK4566","LU0965509283.SGD","LU1571399168.USD","IE00B7SZLL34.SGD","LU0965509101.SGD","LU1778281490.HKD","LU1934455863.HKD","LU1066053197.SGD","SG9999015945.SGD","IE00BSNM7G36.USD","LU1839511570.USD","BK4139","BK4583","LU2087621335.USD","LU0122379950.USD","LU1934455277.USD","LU1037948897.HKD","IE00B19Z3581.USD","LU0965509010.AUD","LU2089984988.USD","IE00BKVL7J92.USD","LU2112291526.USD","BK4578","LU1585245621.USD","LU2357627491.SGD","LU0109394709.USD","LU0859254822.USD","IE00B19Z3B42.SGD","BIB","LU0320765992.SGD","LU1061106388.HKD","BK4532","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663018885","title":"Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo","url":"https://stock-news.laohu8.com/highlight/detail?id=2663018885","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663018885?lang=en_us&edition=fundamental","pubTime":"2026-08-29 01:20","pubTimestamp":1787937637,"startTime":"0","endTime":"0","summary":"Gilead Sciences stock was down roughly 2% on Friday alongside an FDA update concerning HIV drug Bixlenvo.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/gilead-sciences-stock-gild-slips-2-despite-fda-approval-of-bixlenvo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/gilead-sciences-stock-gild-slips-2-despite-fda-approval-of-bixlenvo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIB","LU0320765992.SGD","LU0114720955.EUR","TBXU","LU1057294990.SGD","IE00B19Z3581.USD","IBB","SG9999015986.USD","SG9999015945.SGD","LU2112291526.USD","BK4566","BK4532","LU1037948541.HKD","LU0109394709.USD","LU1934455194.USD","LU1934455863.HKD","LU1066051498.USD","IE00B3T34201.USD","IE00BKVL7J92.USD","GILD","LU0122379950.USD","LU1674673691.USD","LU2357627491.SGD","LU0965509010.AUD","BK4585","IBBQ","BK4588","SG9999015978.USD","LU1585245621.USD","BK4578","BMED","BBH","LU0823416689.USD","LU0889565916.HKD","MEDI","LU1778281490.HKD","IE0002270589.USD","LU0882574055.USD","LU1037948897.HKD","LU1066053197.SGD","LU1571399168.USD","LU1934455277.USD","TMED","LU0965509101.SGD","BK4139","LABU","IE00B19Z3B42.SGD","LU0859254822.USD","IE00BSNM7G36.USD","IE00B7SZLL34.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662762030","title":"Gilead Breaks Ground on Foster City Biologics Facility in $32 Billion US Investment Push","url":"https://stock-news.laohu8.com/highlight/detail?id=2662762030","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662762030?lang=en_us&edition=fundamental","pubTime":"2026-08-28 10:17","pubTimestamp":1787883449,"startTime":"0","endTime":"0","summary":"Gilead breaks ground on Foster City biologics facility in $32 billion US investment pushGilead broke ground on its Chess biologics facility at its Foster City, California headquarters as part of a pla","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL98vB5b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BMED","BK4578","LU0965509101.SGD","TBXU","LU1037948541.HKD","BBH","LU0109394709.USD","LU0889565916.HKD","SG9999015952.SGD","LU1061106388.HKD","LU0859254822.USD","BK4568","LU1066053197.SGD","LU1037948897.HKD","IBB","IE00BKVL7J92.USD","LU1430594728.SGD","IE00BSNM7G36.USD","IBBQ","BIB","BK4583","BK4588","IE0002270589.USD","LU0320765992.SGD","LU2087621335.USD","TMED","LU1934455194.USD","LU2357627491.SGD","LU0965509283.SGD","LU2468319806.SGD","LU0234570918.USD","LU0823416689.USD","LU0289739699.SGD","MEDI","LU1934455863.HKD","IE00B7SZLL34.SGD","LU1674673691.USD","LU0965509010.AUD","LU1674673428.USD","LU0058720904.USD","GILD","LU2112291526.USD","LU0861579265.USD","LU0965508806.USD","LU1057294990.SGD","IE00B19Z3581.USD","LU1066051498.USD","LU1571399168.USD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662394370","title":"Gilead Sciences Director Anthony Welters Disposes of USD 2.64 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2662394370","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662394370?lang=en_us&edition=fundamental","pubTime":"2026-08-28 06:45","pubTimestamp":1787870729,"startTime":"0","endTime":"0","summary":"Gilead Sciences director Anthony Welters disposes of USD 2.64 million in common sharesGilead director Anthony Welters exercised stock options for 18,000 shares on Aug. 26, 2026 at prices of USD 60.67 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL29Bbzm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead Sciences Director Anthony Welters Disposes of USD 2.64 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BIB","LU1839511570.USD","LU1571399168.USD","BK4585","BK4139","LU0965509101.SGD","LU1585245621.USD","BBH","MEDI","LU1934455863.HKD","LU0058720904.USD","BK4583","GILD","IE00B3T34201.USD","LU0861579265.USD","IE00B19Z3581.USD","LU1066051498.USD","LU0965509010.AUD","BK4588","LU0320765992.SGD","IE00BSNM7G36.USD","LU1037948897.HKD","LU0122379950.USD","IE00B19Z3B42.SGD","LU1023059063.AUD","LU2112291526.USD","LU0823416689.USD","BK4532","TMED","IE0002270589.USD","LU1430594728.SGD","LU0889565916.HKD","LU2087621335.USD","TBXU","LU2324357040.USD","LU0289739699.SGD","IE00B7SZLL34.SGD","LU0109394709.USD","LU1057294990.SGD","IBB","IBBQ","LU1674673428.USD","LU0965508806.USD","BK4578","SG9999015986.USD","BK4566","LU0859254822.USD","BMED","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662036301","title":"US FDA Approves Gilead's Once-Daily Combination Pill for HIV Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036301","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662036301?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:50","pubTimestamp":1787867441,"startTime":"0","endTime":"0","summary":"US FDA approves Gilead's once-daily combination pill for HIV treatmentAug 27 -The U.S. Food and Drug Administration has approved Gilead Sciences'GILD.Oonce daily oral combination pill for treatment of adults whose HIV has already been reduced to very low levels, the company said on Thursday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4N44O24M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU0965509010.AUD","BK4139","LU1585245621.USD","LU0122379950.USD","LU1061106388.HKD","LU1934455863.HKD","LU0114720955.EUR","LU1934455277.USD","IBB","IE00B19Z3B42.SGD","LU1066051498.USD","SG9999015945.SGD","LU2357627491.SGD","LU0889565916.HKD","BK4578","IE00B3T34201.USD","LU1674673428.USD","BK4583","IE00B7SZLL34.SGD","LU0965509101.SGD","LU0861579265.USD","IE0002270589.USD","LU2324357040.USD","TMED","GILD","LU0882574055.USD","BMED","LU0234570918.USD","LU0289739699.SGD","LU0320765992.SGD","LU1037948541.HKD","LU1037948897.HKD","LU2468319806.SGD","LU1778281490.HKD","IE00B19Z3581.USD","LU1057294990.SGD","BK4585","IBBQ","BBH","LU1839511570.USD","SG9999015952.SGD","LU0965508806.USD","TBXU","MEDI","BIB","LU1023059063.AUD","BK4566","IE00BZ1G4Q59.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662036807","title":"U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults with Hiv, Including Those on Complex Regimens","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036807","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662036807?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:47","pubTimestamp":1787867220,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUA7M9KZ1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2468319806.SGD","LU0289739699.SGD","LU1057294990.SGD","IBB","LU1839511570.USD","BK4583","TBXU","LU1571399168.USD","LU1934455194.USD","LU1430594728.SGD","TMED","BMED","LU0320765992.SGD","LU0889565916.HKD","SG9999015978.USD","LU0965509010.AUD","BIB","LU1066051498.USD","LU2089984988.USD","LU0882574055.USD","BK4532","LU1934455863.HKD","LU1934455277.USD","LU0861579265.USD","IE00B19Z3B42.SGD","BBH","BK4566","LU0234570918.USD","BK4585","LU2112291526.USD","LU1061106388.HKD","IBBQ","BK4568","MEDI","LU2087621335.USD","LU1037948897.HKD","IE00BKVL7J92.USD","LU0965509283.SGD","IE00B7SZLL34.SGD","BK4588","BK4550","LU0823416689.USD","GILD","LU1066053197.SGD","IE00B3T34201.USD","IE00BZ1G4Q59.USD","LU0109394709.USD","BK4578","LU1778281490.HKD","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662848580","title":"Novartis AG Falls Thursday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2662848580","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662848580?lang=en_us&edition=fundamental","pubTime":"2026-08-28 00:15","pubTimestamp":1787847300,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novartis AG  shed 2.0% to CHF124.64 Thursday on what proved to be an overall negative trading session for the stock market, with the Swiss Market Index SMI Index  falling 1.1% to 14,384.37.Novartis AG closed CHF6.86 short of its 52-week high of CHF131.50, which the company reached on July 29, 2026.Trading volume was 1,890,777, compared to the 50-day average trading volume of 2,478,777.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0208291251.USD","LU0070302665.USD","IE00BJT1NW94.SGD","BK4007","BK4585","IE0002141913.USD","NVS","BK4532","IE00BFTCPJ56.SGD","BK4588","IE00B2B36J28.USD","IE0009355771.USD","LU0211331839.USD","IE00B4R5TH58.HKD","LU0320765489.SGD","IE00BJJMRZ35.SGD","PPH","MEDX","BK4578"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662440957","title":"Moderna Inc. Stock Falls 5.8%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2662440957","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662440957?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:33","pubTimestamp":1787776380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. slid 5.8% to $149.66 on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 0.1% to 26,130.20 and Dow Jones Industrial Average falling 0.2% to 53,463.88.Moderna Inc. closed 15.3% short of its 52-week high of $176.66, which the company reached on August 19th.The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 1.1% to $270.00, Pfizer Inc. fell 0.9% to $28.30, and Gilead Sciences Inc. fell 0.46% to $148.09.Trading volume totaled 21.8 million, compared to the 50-day average of 16.1 million.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","TBXU","MRNY","BBH","LU2324357040.USD","BMED","LU1037948541.HKD","IBB","LU1674673691.USD","SG9999015952.SGD","GILD","BK4551","LU0058720904.USD","TMED","IBBQ","SG9999015978.USD","IE0002270589.USD","LU0965508806.USD","MEDI","LU1674673428.USD","LU0234570918.USD","LU0861579265.USD","LU0965509283.SGD","LU1571399168.USD","LU1934455863.HKD","IE00B7SZLL34.SGD","LU0965509101.SGD","BK4548","LU1839511570.USD","WDNA","LU2087621335.USD","LU0122379950.USD","IE00B19Z3581.USD","MRNX","BK4578","LU1585245621.USD","LU2357627491.SGD","BK4534","GNOM","LGHT","BK4533","LU0109394709.USD","MRNA","IDNA","LU1057294990.SGD","BIB","LU0320765992.SGD","LU1061106388.HKD","BK4532","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129968594","title":"Novartis Secures New Chinese Approval for Key Radiopharmaceutical Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=1129968594","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129968594?lang=en_us&edition=fundamental","pubTime":"2026-08-26 08:50","pubTimestamp":1787705420,"startTime":"0","endTime":"0","summary":"On August 25, Novartis AG (NVS.US) announced that its radiopharmaceutical lutetium [177Lu] vipivotide tetraxetan (Chinese brand name: Paiweitou) received a new indication approval in China. The...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","IE0009355771.USD","IE00BFTCPJ56.SGD","LU0208291251.USD","IE00BJJMRZ35.SGD","BK4588","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","BK4007","PPH","LU0320765489.SGD","NVS","LU0070302665.USD","01477","BK4578","IE00B2B36J28.USD","MEDX","BK4585","BK1191","BK1574","LU0211331839.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662175230","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2662175230","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662175230?lang=en_us&edition=fundamental","pubTime":"2026-08-26 04:35","pubTimestamp":1787690100,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  rose 1.38% to $148.77 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.32% to 7,677.28 and the Dow Jones Industrial Average  rising 0.30% to 53,577.40.This was the stock's third consecutive day of gains.Gilead Sciences Inc. closed 5.42% below its 52-week high of $157.29, which the company achieved on February 11th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson  rose 0.53% to $273.14, Pfizer Inc.  rose 2.15% to $28.57, and Abbott Laboratories  fell 0.46% to $116.13.Trading volume  remained 2.7 million below its 50-day average volume of 7.3 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 25, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3T34201.USD","LU0965509101.SGD","LU1585245621.USD","LU0965509283.SGD","BK4532","TBXU","MEDI","LU0882574055.USD","IBBQ","LU0058720904.USD","LU0861579265.USD","IE00BKVL7J92.USD","IE00B19Z3581.USD","BK4566","LU1066051498.USD","LU1934455863.HKD","LU0122379950.USD","LU0889565916.HKD","LU1057294990.SGD","LU2112291526.USD","SG9999015952.SGD","BK4578","SG9999015986.USD","LU0289739699.SGD","IE0002270589.USD","LU1839511570.USD","LU1037948897.HKD","IE00BZ1G4Q59.USD","LU1061106388.HKD","TMED","LU1037948541.HKD","SG9999015945.SGD","LU0859254822.USD","IE00BSNM7G36.USD","BBH","LU1934455194.USD","BK4550","LU2087621335.USD","LU1674673428.USD","LU2357627491.SGD","IBB","LU1066053197.SGD","BMED","LU1674673691.USD","LU0109394709.USD","IE00B7SZLL34.SGD","BK4585","GILD","LU0320765992.SGD","BK4139","BK4568","LU2089984988.USD","LU2324357040.USD","LU0234570918.USD","LU0965509010.AUD","LU1023059063.AUD","LU0114720955.EUR","BK4583","IE00B19Z3B42.SGD","LU1934455277.USD","LU1571399168.USD","LU1778281490.HKD","SG9999015978.USD","LU1430594728.SGD","LU2468319806.SGD","LU0965508806.USD","LU0823416689.USD","BK4588","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662175580","title":"BeOne Medicines' Tacabrutideg Presents 'Sizable Opportunity' in CSU, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2662175580","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662175580?lang=en_us&edition=fundamental","pubTime":"2026-08-25 23:12","pubTimestamp":1787670744,"startTime":"0","endTime":"0","summary":"BeOne Medicines'  BTK degrader tacabrutideg presents a \"sizable opportunity\" in chronic spontaneous urticaria or CSU, RBC Capital Markets said in a Tuesday note.CSU is an inflammatory skin condition that can be a major market with peak sales estimates of about $3 billion, the brokerage said. BTK degraders have the potential to top BTK inhibitors in CSU, likely exceeding inhibitors in terms of potency and effect durability, RBC noted.Nurix Therapeutics  has reported that its BTK degrader bexobrutideg demonstrated greater potency in CSU compared with Novartis'  BTK inhibitor remibrutinib, and RBC sees tacabrutideg's overall efficacy profile as \"broadly comparable\" with bexobrutideg, according to the note.BeOne Medicines is planning to advance tacabrutideg to phase 2 studies in CSU, RBC noted.RBC has an outperform rating and $450 price target on BeOne Medicines.Price: 376.42, Change: +4.44, Percent Change: +1.19","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","LU0320765489.SGD","IE00B4R5TH58.HKD","LU0208291251.USD","IE00BJT1NW94.SGD","LU0211331839.USD","IE0002141913.USD","MDCO","ONC","BK4007","BK4532","BK4139","IE00BJJMRZ35.SGD","BK4526","IE00B2B36J28.USD","BK4578","IE00BFTCPJ56.SGD","MEDX","PPH","NRIX","LU0070302665.USD","NVS","IE0009355771.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662820617","title":"Moderna Inc. Stock Slides 4.3%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2662820617","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662820617?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:34","pubTimestamp":1787603640,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. slipped 4.3% to $138.89 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.3% to 53,417.16 and the NASDAQ Composite Index falling 0.8% to 25,980.19.Moderna Inc. closed 21.4% short of its 52-week high of $176.66, which the company reached on August 19th.The stock underperformed when compared to some of its peers, as Johnson & Johnson rose 1.0% to $273.04, Pfizer Inc. fell 0.4% to $27.97, and Gilead Sciences Inc. rose 0.42% to $146.74.Trading volume totaled 31.3 million, compared to the 50-day average of 14.7 million.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","MRNY","LU2468319806.SGD","LU0122379950.USD","GILD","LU2089984988.USD","IE00BKVL7J92.USD","BK4534","LU1037948897.HKD","MEDI","TBXU","LU1057294990.SGD","IE00BSNM7G36.USD","BIB","LU0289739699.SGD","IE00B3T34201.USD","LU0109394709.USD","LU1061106388.HKD","BK4578","IE00B19Z3B42.SGD","MRNA","BK4139","LGHT","LU1037948541.HKD","LU2357627491.SGD","BK4568","IDNA","IBB","LU1934455277.USD","LU2324357040.USD","IBBQ","TMED","MRNX","BK4548","SG9999015952.SGD","LU0965509283.SGD","BK4566","IE0002270589.USD","LU0114720955.EUR","LU0859254822.USD","LU1839511570.USD","BMED","LU1585245621.USD","LU0320765992.SGD","GNOM","BBH","SG9999015986.USD","BK4532","WDNA","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662205709","title":"Lakefront Biotherapeutics Wins FDA Orphan Drug Status for Gamgertamig in Pemphigus","url":"https://stock-news.laohu8.com/highlight/detail?id=2662205709","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662205709?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:01","pubTimestamp":1787601693,"startTime":"0","endTime":"0","summary":"Lakefront Biotherapeutics wins FDA orphan drug status for gamgertamig in pemphigusFDA granted orphan drug designation to gamgertamig for pemphigus.The drug already holds FDA fast track and orphan stat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL5cnKbj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015978.USD","BCDF","LU0859254822.USD","LU2324357040.USD","SG9999014039.USD","SG9999015952.SGD","LU2095319765.USD","BMED","LU1430594728.SGD","IBBQ","BBH","IE0002270589.USD","LU2210150020.SGD","LU0965509010.AUD","LU0234570918.USD","GILD","IE00BN0W2W23.USD","LU0122379950.USD","IE00BKPKM429.USD","NDAQ","SG9999014013.SGD","IE00B19Z3B42.SGD","IE00BN0W2T93.GBP","BK4578","LU1037948541.HKD","LU0289739699.SGD","IE00BQXX3F31.USD","LU0965508806.USD","LU2087621335.USD","LU2089984988.USD","BK4550","TBXU","BK4139","LU2210149790.SGD","IE00BN0W2V16.EUR","LU1674673691.USD","IE00BKVL7J92.USD","IBB","MEDI","LU1066051498.USD","BIB","BK4566","IE00B64PRP62.GBP","IE00BZ1G4Q59.USD","IE00BQXX3C00.GBP","LU0320765992.SGD","TMED","LU0861579265.USD","LU1023059063.AUD","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661213210","title":"Funds: What a Top Biotech Fund is Buying Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2661213210","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661213210?lang=en_us&edition=fundamental","pubTime":"2026-08-22 09:30","pubTimestamp":1787362200,"startTime":"0","endTime":"0","summary":"It's hard to find a more experienced biotech investor than Evan McCulloch. The manager of Franklin Biotechnology Discovery has been running the $1.2 billion fund since 1997.That matters in this highly","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","REGN","LU1093756325.SGD","SG9999013999.USD","LU0859254822.USD","BIB","IBBQ","BK4568","LU0154245673.USD","SG9999001440.SGD","BBH","LU1430594728.SGD","IE00B894F039.SGD","LU0882574055.USD","LU2468319806.SGD","BK4583","LU0868494617.USD","LU1983299246.USD","IE00B4R5TH58.HKD","PBE","BK4585","SG9999001176.SGD","IE0002270589.USD","LU2324357040.USD","SG9999015952.SGD","SG9999015986.USD","IE00BSNM7G36.USD","LU1571399168.USD","LU0058720904.USD","BMED","LU0965509101.SGD","MEDI","LU2357627491.SGD","BK4139","IE00B19Z9Z06.USD","LU0823434583.USD","BK4581","XBI","LU1674673691.USD","LU0053666078.USD","LU1934455863.HKD","LU2362541273.HKD","LU0061475181.USD","BK4588","IE00BFTCPJ56.SGD","IDNA","BK4567","LU2087621335.USD","LU2462157665.USD","LU1023059063.AUD","IE00BZ1G4Q59.USD","LU2362540622.SGD","SG9999015978.USD","GILD","LU1061106388.HKD","LU1057294990.SGD","SGXZ57979304.SGD","LU0823434740.USD","LU2242646821.SGD","PJP","BK4578","IBB","LU1069344957.HKD","LU1974910355.USD","IE00B19Z9P08.USD","LU1037948897.HKD","LU0154245756.USD","IE00B2B36J28.USD","LU0965509283.SGD","IE00B19Z3B42.SGD","LU0122379950.USD","BK4534","LU0289739699.SGD","LU1934455194.USD","LU1778281490.HKD","LU1066051498.USD","SG9999015945.SGD","IE0002141913.USD","LU1037948541.HKD","BK4550","LU0256863811.USD","SG9999001176.USD","BK4532","IE00BN0W2V16.EUR","LU0965509010.AUD","LU2417539215.USD","LU1066053197.SGD","LU2106854487.HKD","LU2023250504.SGD","LU0432979614.USD","TMED","BK4599","LU1585245621.USD","LU1917777945.USD","IE00BN0W2W23.USD","AMGN","LU2242652126.USD","IE00B19Z3581.USD","LU2362541513.USD","IE00B7SZLL34.SGD","LU2456880835.USD","IE00B3T34201.USD","LU1934455277.USD","IE00BJT1NW94.SGD","IE00BKVL7J92.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","BK4533","BK4566","IE00BN0W2T93.GBP","LU0861579265.USD","LU0417517546.SGD","JAZZ","LU1093756168.USD","LU1035775433.USD","VRTX","BK4007","LU0079474960.USD","LU2112291526.USD","TBXU","LU0114720955.EUR","LU0965508806.USD","LU0109394709.USD","04332","IE00BZ9MQY76.HKD","LU1839511570.USD","LU2237438978.USD","LU1674673428.USD","LU0823416689.USD","LU0889565916.HKD","LU2236285917.USD","GNMX","LU0234570918.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661940352","title":"Gilead Declares Q3 2026 Dividend of R$ 0.24 Per Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2661940352","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661940352?lang=en_us&edition=fundamental","pubTime":"2026-08-22 01:58","pubTimestamp":1787335117,"startTime":"0","endTime":"0","summary":"Gilead declares Q3 2026 dividend of R$ 0.24 per unitGilead Sciences set a Q3 2026 distribution of R$ 0.24 per unit for BRGILDBDR 000.Last day to trade with rights: Sept. 11, 2026.Payment date: Oct. 5,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL12Yy9R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066053197.SGD","LU1037948897.HKD","LU2089984988.USD","TMED","BK4550","BK4583","LU2112291526.USD","LU1585245621.USD","LU2357627491.SGD","BK4585","LU1674673691.USD","LU1037948541.HKD","LU0122379950.USD","LU1023059063.AUD","BK4568","IE0002270589.USD","BBH","IE00B3T34201.USD","SG9999015986.USD","BK4578","SG9999015952.SGD","LU0859254822.USD","LU0965508806.USD","LU0965509101.SGD","IE00BSNM7G36.USD","LU0320765992.SGD","BIB","LU2468319806.SGD","LU0114720955.EUR","LU0965509283.SGD","BK4588","IE00B19Z3B42.SGD","LU0889565916.HKD","BK4139","LU2324357040.USD","IBB","MEDI","IE00B7SZLL34.SGD","BK4532","LU1674673428.USD","LU0882574055.USD","IBBQ","LU1061106388.HKD","LU1430594728.SGD","BMED","LU0823416689.USD","IE00BKVL7J92.USD","TBXU","GILD","LU0965509010.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661232279","title":"Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2661232279","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661232279?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:35","pubTimestamp":1787258100,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slipped 2.82% to $143.44 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.87% to 7,641.16 and Dow Jones Industrial Average  falling 1.32% to 52,759.21.The stock's fall snapped a seven-day winning streak.Gilead Sciences Inc. closed 8.81% below its 52-week high of $157.29, which the company achieved on February 11th.The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson  fell 2.21% to $267.37, Pfizer Inc.  fell 1.59% to $27.79, and Abbott Laboratories  fell 0.25% to $114.14.Trading volume  remained 286,153 below its 50-day average volume of 7.4 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 20, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU1066051498.USD","LU1571399168.USD","TMED","IBB","LU0965509010.AUD","LU1839511570.USD","LU2087621335.USD","LU1430594728.SGD","BK4583","BK4566","IE00B7SZLL34.SGD","BK4588","BK4568","LU0320765992.SGD","LU0114720955.EUR","LU1023059063.AUD","LU0861579265.USD","LU1061106388.HKD","LU1934455863.HKD","BK4139","LU0965509283.SGD","BMED","LU0234570918.USD","LU0289739699.SGD","LU1585245621.USD","BK4578","LU0058720904.USD","LU2324357040.USD","SG9999015978.USD","BK4550","IBBQ","IE00B19Z3581.USD","IE00BSNM7G36.USD","LU1057294990.SGD","BK4532","LU0965508806.USD","BK4585","LU2468319806.SGD","LU1934455277.USD","SG9999015945.SGD","IE00BKVL7J92.USD","GILD","MEDI","TBXU","LU0882574055.USD","LU1934455194.USD","LU0965509101.SGD","IE0002270589.USD","LU1778281490.HKD","SG9999015986.USD","LU0122379950.USD","LU2112291526.USD","LU0109394709.USD","IE00B3T34201.USD","IE00BZ1G4Q59.USD","LU1066053197.SGD","LU0823416689.USD","LU1037948897.HKD","LU1037948541.HKD","LU1674673691.USD","BBH","BIB","LU1674673428.USD","IE00B19Z3B42.SGD","LU2089984988.USD","SG9999015952.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661232427","title":"Moderna Inc. Stock Slips 23.5%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2661232427","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661232427?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:33","pubTimestamp":1787257980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. cratered 23.5% to $133.32 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.0% to 26,067.17 and Dow Jones Industrial Average falling 1.3% to 52,759.21.Moderna Inc. closed 24.5% short of its 52-week high of $176.66, which the company reached on August 19th.The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 2.2% to $267.37, Pfizer Inc. fell 1.6% to $27.79, and Gilead Sciences Inc. fell 2.82% to $143.44.Trading volume totaled 97.3 million, compared to the 50-day average of 11.2 million.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BMED","LU1585245621.USD","BK4551","BK4578","TBXU","LU1037948541.HKD","BBH","LU0109394709.USD","LU1778281490.HKD","GNOM","LU1066053197.SGD","IE00B19Z3B42.SGD","IBB","MRNY","LU0114720955.EUR","WDNA","LU1430594728.SGD","LU1839511570.USD","BK4550","BK4533","IE00BSNM7G36.USD","IBBQ","BIB","TMED","LU1934455194.USD","LU2468319806.SGD","MEDI","LU0823416689.USD","LU0289739699.SGD","IE00B3T34201.USD","IE00B7SZLL34.SGD","LU1674673691.USD","LU0965509010.AUD","BK4548","LU1674673428.USD","LU0058720904.USD","BK4139","GILD","LU2112291526.USD","BK4566","LGHT","MRNX","IDNA","LU1023059063.AUD","SG9999015952.SGD","MRNA","SG9999015945.SGD","LU0882574055.USD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473115","title":"Moderna Inc. Stock Rallies 177.0%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473115","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473115?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:32","pubTimestamp":1787171520,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. sailed 177.0% to $174.38 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.2% to 26,331.09 and the Dow Jones Industrial Average rising 0.2% to 53,463.05.Moderna Inc. hit a new 52-week high, surpassing its previous peak of $85.60, which the company achieved on July 6th.The stock outperformed some of its peers, as Johnson & Johnson rose 0.8% to $273.41, Pfizer Inc. rose 3.6% to $28.24, and Gilead Sciences Inc. rose 2.90% to $147.60.Trading volume totaled 187.3 million, compared to the 50-day average of 7.3 million.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","LU0234570918.USD","IE0002270589.USD","LU1778281490.HKD","LU0861579265.USD","MRNX","TBXU","LU1934455277.USD","SG9999015952.SGD","LU0965508806.USD","WDNA","GILD","LU2324357040.USD","LU1934455194.USD","TMED","BIB","BMED","IE00B19Z3581.USD","LU0889565916.HKD","IE00B7SZLL34.SGD","MRNY","LU1430594728.SGD","BBH","IE00BKVL7J92.USD","GNOM","IBBQ","LU0122379950.USD","LU0965509101.SGD","LU1934455863.HKD","BK4533","BK4588","IE00B19Z3B42.SGD","BK4578","LU0965509283.SGD","MRNA","LGHT","LU1571399168.USD","MEDI","LU1585245621.USD","LU0289739699.SGD","LU1674673428.USD","LU0965509010.AUD","IE00BZ1G4Q59.USD","BK4139","IBB","IDNA","SG9999015978.USD","BK4548","BK4583","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660047819","title":"Novartis AG Stock (NVS) Moved Up by 3.82% on Aug 19: Key Drivers Unveiled","url":"https://stock-news.laohu8.com/highlight/detail?id=2660047819","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660047819?lang=en_us&edition=fundamental","pubTime":"2026-08-20 03:15","pubTimestamp":1787166944,"startTime":"0","endTime":"0","summary":"• Novartis reported strong financial execution driven by innovative oncology and cardiovascular treatments.\n• Institutional investors favored the company amid broader sector rotation into defensive healthcare assets.\n• Novartis AG generated $56.33B in annual revenue with a net profit of $13.98B.","market":"nz","thumbnail":"https://resource.tradingkey.com/uploads/20251024/Novartis-369e71de347f479fa3f300f9d7904bc5.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20251024/Novartis-369e71de347f479fa3f300f9d7904bc5.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262118847-market-movers-nvs-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPH","NVS","IE0002141913.USD","BK4588","IE00B2B36J28.USD","LU0320765489.SGD","BK4578","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","BK4532","BK4585","IE0009355771.USD","IE00BJT1NW94.SGD","MEDX","LU0211331839.USD","LU0208291251.USD","IE00BJJMRZ35.SGD","BK4007","LU0070302665.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":25,"code":"91000000","status":"200"}]}}